United States· US:64980-640_3249a3d2-4951-f09b-e063-6294a90a9f79
Ipratropium Bromide
A medicinal product containing ipratropium bromide, registered in United States by Rising Pharma Holdings, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- IPRATROPIUM BROMIDE
- Manufacturer
- Rising Pharma Holdings, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 26, 2026
Packs & prices · 6
- ndc1164980640021 POUCH in 1 CARTON (64980-640-02) / 25 VIAL, SINGLE-DOSE in 1 POUCH / 2.5 mL in 1 VIAL, SINGLE-DOSE
- ndc1164980640031 POUCH in 1 CARTON (64980-640-03) / 30 VIAL, SINGLE-DOSE in 1 POUCH / 2.5 mL in 1 VIAL, SINGLE-DOSE
- ndc1164980640062 POUCH in 1 CARTON (64980-640-06) / 30 VIAL, SINGLE-DOSE in 1 POUCH / 2.5 mL in 1 VIAL, SINGLE-DOSE
- ndc1164980-640-02
- ndc1164980-640-03
- ndc1164980-640-06
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ipratropium bromide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumCombivent 0.5 mg/2.5 ml - 2.5 mg/2.5 mlBoehringer Ingelheim
- United KingdomAtrovent 20micrograms/dose AutohalerBoehringer Ingelheim Ltd
- FinlandAtroventParanova Oy
- SwedenAtrovent 0,25 mg/ml Lösning för nebulisatorAbacus Medicine A/S
- FranceATROVENT 20 microgrammes/dose, solution pour inhalation en flacon pressuriséBOEHRINGER INGELHEIM FRANCE
- GermanyAtroventBoehringer Ingelheim Pharma Gmbh & Co. Kg
- NetherlandsAtrovent 20 microgram/dosis, aërosol, oplossingBoehringer Ingelheim B.V.
- CanadaAA-IPRAVENTAA PHARMA INC
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Atrovent - Dosieraerosol, Ipratropiumbromid Infectopharm
- Belgium · Atrovent, Atrovent Hfa
- Cyprus · Atrovent
- Czechia · Atrovent, Atrovent N
- Germany · Atrovent, Atrovent Ls
- Denmark · Atrovent, Ipratropiumbromid Teva
- Estonia · Atrovent N
- Spain · Atroaldo, Atrovent
- Finland · Atrovent, Atrovent Eco
- France · Atrovent, Atrovent Adultes
- United Kingdom (Northern Ireland) · Atrovent Inhaler Cfc-Free, Atrovent Udvs
- Greece · Atrovent, Broncovent
- Croatia · Atrovent, Atrovent N
- Hungary · Atrovent N
- Ireland · Atrovent 250 Udvs, Atrovent 500 Udvs
- Iceland · Atrovent, Lomuspray
- Italy · Atem, Nasipral
- Lithuania · Atrovent N
- Luxembourg · Atrovent, Atrovent Hfa
- Malta · Atroaldo, Atrovent Inhaler Cfc-Free
- Netherlands · Atrovent, Atrovent Unit Dose
- Norway · Atrovent, Ipraxa
- Poland · Atrodil, Atrovent
- Portugal · Atrovent, Atrovent Pa
- Romania · Ipravent Inhaler
- Sweden · Atrovent, Ipravent
- Slovakia · Atrovent N
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dcc50597-d1f2-4da1-95df-37f8b645f9c6 GET /v1/drugs/dcc50597-d1f2-4da1-95df-37f8b645f9c6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "RESPIRATORY (INHALATION)",
"source": "ndc",
"strength": ".5",
"substance": "IPRATROPIUM BROMIDE",
"productndc": "64980-640",
"dosage_form": "SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/2.5mL",
"application_number": "ANDA075562",
"marketing_category": "ANDA"
}See everything about ipratropium bromide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.